Part 5/10:
The Emergence of Synthetic Biology
Central to Carnicom's findings is a class of materials referred to as cross-domain biological entities (CDBs), which imply a complex interplay of biological structures not confined to traditional classifications. This broad classification not only encompasses synthetic biology but also highlights a fundamental shift in how we understand health and disease, particularly in relation to the COVID vaccines.